Cargando…
Antigen sparing and enhanced protection using a novel rOv-ASP-1 adjuvant in aqueous formulation with influenza vaccines
Influenza is one of the most common infectious diseases endangering the health of humans, especially young children and the elderly. Although vaccination is the most effective means of protection against influenza, frequent mutations in viral surface antigens, low protective efficacy of the influenz...
Autores principales: | Jiang, Jiu, Fisher, Erin M., Hensley, Scott E., Lustigman, Sara, Murasko, Donna M., Shen, Hao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4080630/ https://www.ncbi.nlm.nih.gov/pubmed/24681229 http://dx.doi.org/10.1016/j.vaccine.2014.03.046 |
Ejemplares similares
-
Enhanced humoral response to influenza vaccine in aged mice with a novel adjuvant, rOv-ASP-1
por: Jiang, Jiu, et al.
Publicado: (2016) -
rOv-ASP-1, a recombinant secreted protein of the helminth Onchocercavolvulus, is a potent adjuvant for inducing antibodies to ovalbumin, HIV-1 polypeptide and SARS-CoV peptide antigens
por: MacDonald, Angus J., et al.
Publicado: (2005) -
The Adjuvanticity of an O. volvulus-Derived rOv-ASP-1 Protein in Mice Using Sequential Vaccinations and in Non-Human Primates
por: Wang, Jing, et al.
Publicado: (2012) -
The Immunomodulatory Role of Adjuvants in Vaccines Formulated with the Recombinant Antigens Ov-103 and Ov-RAL-2 against Onchocerca volvulus in Mice
por: Hess, Jessica A., et al.
Publicado: (2016) -
Impaired specific CD8 T cell response with aging is not due to decreased expression of CD90 on TCR transgenic T cells
por: Jiang, Jiu, et al.
Publicado: (2013)